Literature DB >> 22012074

Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Rennolds S Ostrom1, Amy S Bogard, Robert Gros, Ross D Feldman.   

Abstract

Adenylyl cyclases are a ubiquitous family of enzymes and are critical regulators of metabolic and cardiovascular function. Multiple isoforms of the enzyme are expressed in a range of tissues. However, for many processes, the adenylyl cyclase isoforms have been thought of as essentially interchangeable, with their impact more dependent on their common actions to increase intracellular cyclic adenosine monophosphate content regardless of the isoform involved. It has long been appreciated that each subfamily of isoforms demonstrate a specific pattern of "upstream" regulation, i.e., specific patterns of ion dependence (e.g., calcium-dependence) and specific patterns of regulation by kinases (protein kinase A (PKA), protein kinase C (PKC), raf). However, more recent studies have suggested that adenylyl cyclase isoform-selective patterns of signaling are a wide-spread phenomenon. The determinants of these selective signaling patterns relate to a number of factors, including: (1) selective coupling of specific adenylyl cyclase isoforms with specific G protein-coupled receptors, (2) localization of specific adenylyl cyclase isoforms in defined structural domains (AKAP complexes, caveolin/lipid rafts), and (3) selective coupling of adenylyl cyclase isoforms with specific downstream signaling cascades important in regulation of cell growth and contractility. The importance of isoform-specific regulation has now been demonstrated both in mouse models as well as in humans. Adenylyl cyclase has not been viewed as a useful target for therapeutic regulation, given the ubiquitous expression of the enzyme and the perceived high risk of off-target effects. Understanding which isoforms of adenylyl cyclase mediate distinct cellular effects would bring new significance to the development of isoform-specific ligands to regulate discrete cellular actions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012074     DOI: 10.1007/s00210-011-0696-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  70 in total

1.  Residence of adenylyl cyclase type 8 in caveolae is necessary but not sufficient for regulation by capacitative Ca(2+) entry.

Authors:  Karen E Smith; Chen Gu; Kent A Fagan; Biao Hu; Dermot M F Cooper
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

Review 2.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

3.  Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits.

Authors:  Xianlong Gao; Rachna Sadana; Carmen W Dessauer; Tarun B Patel
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

4.  Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin.

Authors:  E J Choi; Z Xia; D R Storm
Journal:  Biochemistry       Date:  1992-07-21       Impact factor: 3.162

5.  Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits.

Authors:  M L Bayewitch; T Avidor-Reiss; R Levy; T Pfeuffer; I Nevo; W F Simonds; Z Vogel
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

6.  Regulation of adenylyl cyclase by protein kinase A.

Authors:  G Iwami; J Kawabe; T Ebina; P J Cannon; C J Homcy; Y Ishikawa
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

Review 7.  Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases.

Authors:  R Iyengar
Journal:  FASEB J       Date:  1993-06       Impact factor: 5.191

Review 8.  Molecular biological approaches to unravel adenylyl cyclase signaling and function.

Authors:  T B Patel; Z Du; S Pierre; L Cartin; K Scholich
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

9.  Motor dysfunction in type 5 adenylyl cyclase-null mice.

Authors:  Tamio Iwamoto; Satoshi Okumura; Kousaku Iwatsubo; Jun-Ichi Kawabe; Koji Ohtsu; Ikuko Sakai; Yoko Hashimoto; Aki Izumitani; Kazunori Sango; Kyoko Ajiki; Yoshiyuki Toya; Satoshi Umemura; Yoshio Goshima; Nobutaka Arai; Stephen F Vatner; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

10.  Inhibition of cloned adenylyl cyclases by mutant-activated Gi-alpha and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment.

Authors:  J Chen; R Iyengar
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  25 in total

1.  The fundamental unit of pain is the cell.

Authors:  David B Reichling; Paul G Green; Jon D Levine
Journal:  Pain       Date:  2013-12       Impact factor: 6.961

2.  A door opener for future research: agonist-induced β3-adrenoceptor desensitization in HEK cells but not CHO cells.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-12       Impact factor: 3.000

3.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

4.  Functional characterization of AC5 gain-of-function variants: Impact on the molecular basis of ADCY5-related dyskinesia.

Authors:  T B Doyle; M P Hayes; D H Chen; W H Raskind; V J Watts
Journal:  Biochem Pharmacol       Date:  2019-02-14       Impact factor: 5.858

5.  Compartmentalized cAMP responses to prostaglandin EP2 receptor activation in human airway smooth muscle cells.

Authors:  Shailesh R Agarwal; Kathryn Miyashiro; Htun Latt; Rennolds S Ostrom; Robert D Harvey
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

6.  Regulation of G protein subunit composition in cardiomyocytes: pharmacological implications.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-09       Impact factor: 3.000

Review 7.  Role of T-type channels in vasomotor function: team player or chameleon?

Authors:  Ivana Y-T Kuo; Lauren Howitt; Shaun L Sandow; Alexandra McFarlane; Pernille B Hansen; Caryl E Hill
Journal:  Pflugers Arch       Date:  2014-01-31       Impact factor: 3.657

Review 8.  cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes.

Authors:  Timothy B Johnstone; Shailesh R Agarwal; Robert D Harvey; Rennolds S Ostrom
Journal:  Mol Pharmacol       Date:  2017-12-07       Impact factor: 4.436

9.  Cyclic Adenosine 3',5'-Monophosphate Elevation and Biological Signaling through a Secretin Family Gs-Coupled G Protein-Coupled Receptor Are Restricted to a Single Adenylate Cyclase Isoform.

Authors:  Andrew C Emery; Xiu-Huai Liu; Wenqin Xu; Maribeth V Eiden; Lee E Eiden
Journal:  Mol Pharmacol       Date:  2015-03-13       Impact factor: 4.436

10.  Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates IL-6 expression in airway smooth muscle cells: differential regulation of gene expression by AC isoforms.

Authors:  Amy S Bogard; Anna V Birg; Rennolds S Ostrom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-12-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.